新生儿复苏中喉罩气道与面罩通气的随机试验
该研究为乌干达开展的3期、开放标签、优效性随机试验,纳入需正压通气的窒息新生儿(估计胎龄≥34周或出生体重≥2000g,或两者兼有),由助产士分别使用喉罩气道或面罩通气。主要复合终点为7天内死亡或住院第1至5天因中重度缺氧缺血性脑病入住NICU,LMA组27.4% vs 面罩组24.4%(校正RR 1.16,95%CI 0.90-1.51,P=0.26),无统计学差异。7天内死亡(21.7% vs 18.4%)和NICU入住伴中重度HIE(11.2% vs 10.1%)亦无差异,预设干预相关不良事件两组相似。结论:在助产士操作下LMA安全但不优于面罩通气。
要点
- 在资源有限地区由助产士操作时,LMA通气安全但不优于面罩通气,不改变现有面罩通气为首选的做法。
- 主要复合终点(7天内死亡或第1至5天中重度HIE入住NICU):LMA组27.4% vs 面罩组24.4%,校正RR 1.16(95%CI 0.90-1.51,P=0.26)。
- 7天内死亡:LMA组21.7% vs 面罩组18.4%,校正RR 1.21(95%CI 0.90-1.63)。
- NICU入住伴中重度HIE:LMA组11.2% vs 面罩组10.1%,校正RR 1.27(95%CI 0.84-1.93)。
- 预设干预相关不良事件频率两组相似,LMA在助产士手中安全。
适用人群与场景
- 需正压通气的新生儿,估计胎龄至少34周或估计出生体重至少2000g,或两者兼有。
- 场景为乌干达由助产士实施新生儿复苏。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 对需正压通气的合格新生儿,由助产士使用喉罩气道(LMA)或面罩通气进行正压通气复苏。
- 原文未提及具体通气参数、药物剂量或疗程。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:3期、开放标签、优效性随机试验,单国(乌干达)开展,LMA组563例、面罩组591例,99.2%获得完整随访。
- 主要复合终点(7天内死亡或住院第1至5天因中重度HIE入住NICU):LMA组154/563(27.4%) vs 面罩组144/591(24.4%),校正RR 1.16(95%CI 0.90-1.51,P=0.26)。
- 7天内死亡:LMA组21.7% vs 面罩组18.4%,校正RR 1.21(95%CI 0.90-1.63)。
- NICU入住伴中重度HIE:LMA组11.2% vs 面罩组10.1%,校正RR 1.27(95%CI 0.84-1.93)。
- 预设干预相关不良事件频率两组相似。
证据类型、等级与局限
- 证据类型:随机对照试验(3期、开放标签、优效性设计)。
- 局限:开放标签、单国单中心(原文未明确中心数)、由助产士操作,结果外推需谨慎。
对床旁实践的改变
- 在资源有限地区由助产士实施新生儿复苏时,LMA可安全使用,但不优于面罩通气,不应改变面罩通气作为首选的地位。
- 适用人群为估计胎龄≥34周或出生体重≥2000g的需正压通气新生儿;不适用于低于此胎龄/体重者(原文未纳入)。
指南或共识出处
- NeoSupra试验(ClinicalTrials.gov NCT03133572),发表于N Engl J Med。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Face-mask ventilation is the most common resuscitation method for birth asphyxia. Ventilation with a cuffless laryngeal mask airway (LMA) has potential advantages over face-mask ventilation during neonatal resuscitation in low-income countries, but whether the use of an LMA reduces mortality and morbidity among neonates with asphyxia is unknown.
METHODS: In this phase 3, open-label, superiority trial in Uganda, we randomly assigned neonates who required positive-pressure ventilation to be treated by a midwife with an LMA or with face-mask ventilation. All the neonates had an estimated gestational age of at least 34 weeks, an estimated birth weight of at least 2000 g, or both. The primary outcome was a composite of death within 7 days or admission to the neonatal intensive care unit (NICU) with moderate-to-severe hypoxic-ischemic encephalopathy at day 1 to 5 during hospitalization.
RESULTS: Complete follow-up data were available for 99.2% of the neonates. A primary outcome event occurred in 154 of 563 neonates (27.4%) in the LMA group and 144 of 591 (24.4%) in the face-mask group (adjusted relative risk, 1.16; 95% confidence interval [CI], 0.90 to 1.51; P = 0.26). Death within 7 days occurred in 21.7% of the neonates in the LMA group and 18.4% of those in the face-mask group (adjusted relative risk, 1.21; 95% CI, 0.90 to 1.63), and admission to the NICU with moderate-to-severe hypoxic-ischemic encephalopathy at day 1 to 5 during hospitalization occurred in 11.2% and 10.1%, respectively (adjusted relative risk, 1.27; 95% CI, 0.84 to 1.93). Findings were materially unchanged in a sensitivity analysis in which neonates with missing data were counted as having had a primary outcome event in the LMA group and as not having had such an event in the face-mask group. The frequency of predefined intervention-related adverse events was similar in the two groups.
CONCLUSIONS: In neonates with asphyxia, the LMA was safe in the hands of midwives but was not superior to face-mask ventilation with respect to early neonatal death and moderate-to-severe hypoxic-ischemic encephalopathy. (Funded by the Research Council of Norway and the Center for Intervention Science in Maternal and Child Health; NeoSupra ClinicalTrials.gov number, NCT03133572.).
参考来源
- Pejovic NJ, Myrnerts Höök S, Byamugisha J, et al. A Randomized Trial of Laryngeal Mask Airway in Neonatal Resuscitation. N Engl J Med. 2020. PMID: 33252870. doi:10.1056/NEJMoa2005333
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。